Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0000947871-22-001163

Director bought 402,000 shares at $3.21 ($1,290,420)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
GORDON CARL L Director 2022-11-08 Purchase +402,000 $3.21 $1,290,420 15,219,994 I
Open-market purchases · 402,000 sh · avg $3.21 · $1,290,420
Loading xslF345X03/ownership.xml…